Biomedical Engineering Reference
In-Depth Information
159. Lu, Y. and P.S. Low, Folate-mediated delivery of macromolecular anticancer
therapeutic agents.
Adv Drug Deliv Rev
, 2002. 54(5): p. 675-93.
160. Xia, W. and P.S. Low, Folate-targeted therapies for cancer.
J Med Chem
, 2010.
53(19): p. 6811-24.
161. Daniels, T.R.,
et al.
, h e transferrin receptor and the targeted delivery of
therapeutic agents against cancer.
Biochimica et Biophysica Acta (BBA)-
General Subjects
, 2012. 1820(3): p. 291-317.
162. Soni, V., D.V. Kohli, and S.K. Jain, Transferrin-conjugated liposomal system
for improved delivery of 5-l uorouracil to brain.
J Drug Target
, 2008. 16(1):
p. 73-8.
163. van Rooy, I.,
et al.
, Comparison of i ve dif erent targeting ligands to enhance
accumulation of liposomes into the brain.
J Control Release
, 2011. 150(1): p.
30-6.
164. Kobayashi, T.,
et al.
, Ef ect of transferrin receptor-targeted liposomal doxo-
rubicin in P-glycoprotein-mediated drug resistant tumor cells.
Int J Pharm
,
2007. 329(1-2): p. 94-102.
165. Koshkaryev, A., A. Piroyan, and V.P. Torchilin, Increased apoptosis in cancer
cells in vitro and in vivo by ceramides in transferrin-modii ed liposomes.
Cancer Biol h er
, 2012. 13(1): p. 50-60.
166. Suzuki, R.,
et al.
, Ef ective anti-tumor activity of oxaliplatin encapsulated in
transferrin-PEG-liposome.
Int J Pharm
, 2008. 346(1-2): p. 143-50.
167. Oliveira, A.C.,
et al.
, Cationic liposome-DNA complexes as gene delivery
vectors: Development and behaviour towards bone-like cells.
Acta Biomater
,
2009. 5(6): p. 2142-51.
168. Zhang, X.,
et al.
, Transferrin receptor targeted lipopolyplexes for delivery of
antisense oligonucleotide g3139 in a murine k562 xenograt model.
Pharm
Res
, 2009. 26(6): p. 1516-24.
169. Zhong, Z.R.,
et al.
, Preparation and characterization of a novel nonviral gene
transfer system: procationic-liposome-protamine-DNA complexes.
Drug
Deliv
, 2007. 14(3): p. 177-83.
170. Mendonca, L.S.,
et al.
, Transferrin receptor-targeted liposomes encapsulat-
ing anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treat-
ment.
Bioconjug Chem
, 2010. 21(1): p. 157-68.
171. Zhu, J.M.,
et al.
, Biomimetic glycoliposomes as nanocarriers for targeting
P-selectin on activated platelets.
Bioconjug Chem
, 2007. 18(5): p. 1366-1369.
172. Chono, S.,
et al.
, Ef ect of surface-mannose modii cation on aerosolized lipo-
somal delivery to alveolar macrophages.
Drug Dev Ind Pharm
, 2010. 36(1):
p. 102-7.
173. Watanabe,T.,
et al.
, Liver target delivery of small interfering RNA to the HCV
gene by lactosylated cationic liposome.
J Hepatol
, 2007. 47(6): p. 744-50.
174. Ikehara, Y.,
et al.
, Ef ective induction of anti-tumor immune responses with
oligomannose-coated liposome targeting to intraperitoneal phagocytic cells.
Cancer Lett
, 2008. 260(1-2): p. 137-45.
175. Hendricks, G.L.,
et al.
, Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal
decoys capture inl uenza A virus.
J Biol Chem
, 2013. 288(12): p. 8061-73.
